The Nanocurcumin Reduces Appetite in Obese Patients with Non-Alcoholic Fatty Liver Disease (NAFLD): A Double-Blind Randomized Placebo-Controlled Clinical Trial

The Nanocurcumin Reduces Appetite in Obese Patients with Non-Alcoholic Fatty Liver Disease (NAFLD): A Double-Blind Randomized Placebo-Controlled Clinical Trial

Objective(s): Various beneficial effects of curcumin have been seen specially as anti-inflammator and antioxidant agent. However, until now no human studies have been done on curcumin’s role in control of appetite. So, the present study was done to determine the effect of nanocurcumin on appetite in...

Full description

Bibliographic Details
Main Authors: SSeyed Ali Jazayeri-Tehrani, Seyed Mahdi Rezayat, Siavash Mansouri, Mostafa Qorbani, Seyed Moayed Alavian, Milad Daneshi-Maskooni, Mohammad-Javad Hosseinzadeh-Attar
Format: Article
Language:English
Published: Mashhad University of Medical Sciences 2018-04-01
Series:Nanomedicine Journal
Subjects:
Appetite
Nanocurcumin
Non-Alcoholic Fatty Liver Disease (NAFLD)
Obesity
Trial
Online Access:http://nmj.mums.ac.ir/article_10442_ba48a11d72e129a1bda68a155212784d.pdf

Similar Items

Similar Items